SCHEMBL3116086

SCHEMBL3116086

CC1C2CCC3C2C(C)(C)CCCC13C

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
UGT2B7 P16662 20/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3001348 0.77 UGT2B7 (0.64) UGT2B7
Isolongifolol SCHEMBL10784534 0.75 UGT2B7 (1.00) UGT2B7
Isolongifolol SCHEMBL29988784 0.75 UGT2B7 (1.00) UGT2B7
Isolongifolol SCHEMBL29511507 0.75 UGT2B7 (1.00) UGT2B7
Isolongifolol SCHEMBL6514140 0.75 UGT2B7 (1.00) UGT2B7
Isolongifolol SCHEMBL29638247 0.75 UGT2B7 (1.00) UGT2B7
SCHEMBL7164598 0.74 UGT2B7 (0.70) UGT2B7
Isolongifolic Acid SCHEMBL29865033 0.74 UGT2B7 (1.00) UGT2B7
Methane SCHEMBL8422391 0.63
Ammonia Solution, Strong SCHEMBL8093569 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2163601-B1 BASE OIL IDEMITSU KOSAN CO (JP) 2014-11-05 EP disclosed
CN-101688141-B Lubricating oil for continuously variable transmission IDEMITSU KOSAN CO 2013-03-20 CN disclosed
US-8338653-B2 Lubricating oil for non-stage transmission IDEMITSU KOSAN CO., LTD. (JP) 2012-12-25 US disclosed
US-20100179079-A1 LUBRICATING OIL FOR NON-STAGE TRANSMISSION IDEMITSU KOSAN CO., LTD (JP) 2010-07-15 US disclosed
CN-101688141-A Lubricating oil for continuously variable transmission IDEMITSU KOSAN CO 2010-03-31 CN disclosed
EP-2163601-A1 LUBRICATING OIL FOR NON-STAGE TRANSMISSION Idemitsu Kosan Co., Ltd. (JP) 2010-03-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179079-A1 LUBRICATING OIL FOR NON-STAGE TRANSMISSION MED25, PTK2, MED12 UGT2B7 3256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.